Kesem Health announces the appointment of Darin Hammers to its Board of Directors

Darin Hammers, an accomplished senior executive with significant experience in sales and sales management in the medical device industry, and specifically in urology, has been appointed to the Board of Directors of Kesem Health.

As the President and Chief Executive Officer of Cogentix Medical, Mr Hammers managed a $25M fund raising in 2016.  In 2018, Mr Hammers led a $239M transaction, selling Cogentix to Laborie Medical Technologies. Other executive roles that Mr Hammers has held include VP of Sales (Urology) at Bard Medical and Director of Sales at Boston Scientific (Urology).  He is currently the CEO of Dysis Medical.

Kesem Health’s initial market is the US, and the company is now in the final stages of preparation for a commercial pilot of its iUFlow™ device.  “With his more than 20 years’ experience, Mr Hammers will have a direct impact on Kesem’s success in its initial market penetration, future fund raising, and setting the strategic direction of the company”, says Gil Hidas, CEO of Kesem Health.   “We welcome Mr Hammers to our growing team and I’m looking forward working with him during 2020 and beyond”.

About Kesem Health
Kesem Health is a digital health company improving the convenience, accuracy, and validity of data in support of the diagnosis and management of urological conditions. Kesem has developed a patented and approved (FDA, TGA, CE Mark) wireless bladder monitoring and measurement platform that enables early, efficient diagnosis and monitoring of urological conditions. Kesem Health’s iUFlow™ is a fully automated, easy to use bladder monitoring solution, implemented on a smart phone platform.